Tenon Medical Inc. (TNON)
NASDAQ (CM) NASDAQ (CM) Primary 
Tenon Medical Reports Second Quarter 2024 Financial Results
~ Second Quarter 2024 Revenue Increased 21% Year-Over-Year ~ ~ Surgical Procedures Increased 7% Year-Over-Year in the Second Quarter 2024 ~ ~ Gross Profit Margin of 52% Marks One Year of Generating Positive Gross Profit ~ ~ Publication of Post-Market Study Interim Analysis Now Imminent ~ LOS GATOS, CA / ACCESSWIRE / August 13, 2024 / Tenon Medical, Inc. (NASDAQ:TNON)(NASDAQ:TNONW) ("Tenon Medical" or the "Company" or "Tenon"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 and Subsequent Highlights Revenue of $901,000 in the second quarter of 2024, a 21% increase over the prior year quarter and a 25% increase over the first quarter of 2024.
Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results
LOS GATOS, CA / ACCESSWIRE / July 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the second quarter 2024 ended June 30, 2024 after market close on Tuesday, August 13, 2024. The Company will also hold a conference call the same day at 4:30 p.m.
